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Abstract
Ovarian folliculogenesis is regulated by both endocrine and intraovarian mechanisms that
coordinate the processes of oocyte growth and somatic cell proliferation and differentiation.
Within the follicle, paracrine interactions between the oocyte and surrounding granulosa cells are
critical for normal cell development and function. This review focuses on the role of paracrine
interactions during early oocyte and follicular development that ensure proper coordination of
oocyte and somatic cell function. Particular emphasis is given to granulosa cell-derived Kit Ligand
(KitL), whose functional importance for oocyte growth has been demonstrated by a wide range of
in vivo and in vitro studies. Reported interactions between KitL and oocyte-derived growth
differentiation factor-9 (GDF9) and bone morphogenetic protein-15 (BMP15) suggest the
molecular basis of oocyte-granulosa cell interactions, but also hint at the complexity of these
communications. These paracrine interactions and the structure of the oocyte-granulosa cell
interface are follicle stage-specific and regulated by FSH. Elucidation of the molecular mechanisms
that promote the development of healthy oocytes with good developmental competence has
potential applications for improving fertility and for in vitro growth systems for oocytes from
domestic animals and humans.
Introduction
Development of the ovarian follicle requires coordination
of the processes of somatic cell proliferation and differen-
tiation with oocyte growth and maturation [1]. Paracrine
interactions between the oocyte and surrounding granu-
losa cells are critical for ensuring this coordination by pro-
moting integrated cellular functions [2-4]. One of the first
ligand-receptor systems to be identified in the ovarian fol-
licle is Kit Ligand (KitL) and the receptor tyrosine kinase
Kit. Since the identification of KitL in 1990 [5-7], numer-
ous in vitro and in vivo studies have provided evidence to
support its critical role in both female and male germ cell
development. While there are several excellent review arti-
cles describing the importance of oocyte-granulosa cell
interactions for normal follicular development [8-11],
this review focuses on the particular role of the granulosa
cell-derived KitL, and its interactions with the oocyte-spe-
cific growth differentiation factor-9 (GDF9) and bone
morphogenetic protein-15 (BMP15/GDF9b). The role of
FSH in regulating these paracrine interactions and the
structure of the oocyte-granulosa cell interface during fol-
licular development will also be addressed.
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Overview of follicular development
Ovarian follicles begin their development as primordial
structures, which consist of an oocyte arrested at the
diplotene stage of the first meiotic division, surrounded
by a few flattened granulosa cells. In rodents, follicle for-
mation occurs synchronously during the first few days
after birth, whereas in domestic animals and primates,
follicle formation occurs during fetal life (reviewed in
[12]). In these species, follicles are formed over a much
longer period and in a less synchronous manner. When
follicles leave the resting pool, the oocyte grows and the
granulosa cells proliferate to form a multi-laminar struc-
ture called a primary or preantral follicle. Once the follicle
reaches a species-specific size, it forms a fluid-filled space
called an antrum. When this stage has been reached, folli-
cles become acutely dependent on gonadotropins for fur-
ther growth and development. The growth phase of the
oocyte occurs during the preantral stage in rodents, and it
is during this time that development of the zona pellucida
occurs, as well as production of mRNA and proteins
required for subsequent fertilization and early embryonic
development. These factors must be stored within the
oocyte, as resumption of meiosis results in transcriptional
silencing [13]. Oocyte developmental competence,
defined as the ability of the oocyte to resume and com-
plete meiosis, and support pre-implantation embryonic
development after fertilization, is acquired gradually dur-
ing folliculogenesis. Although acquisition of develop-
mental competence is positively correlated with oocyte
growth in vivo, the observation that oocytes cultured on
fibroblasts do not grow, but can resume meiosis, indicates
that these two events can be dissociated [14,15]. The
dynamic changes associated with ovarian folliculogenesis
are regulated by endocrine and intraovarian mechanisms
which serve to promote and coordinate this growth [1].
Paracrine control of oocyte-follicle interactions
Within the follicle, paracrine communications between
the oocyte and surrounding granulosa cells are critical for
normal cell development and function [8-11]. This review
focuses on the role of paracrine interactions, in particular
those involving KitL, during early oocyte and follicular
development, and the effects of FSH on those interactions.
In addition, the consequences of dynamic changes in the
structure of the oocyte-granulosa cell interface during
development will be addressed.
Kit ligand-kit interactions
The tyrosine kinase receptor Kit and its ligand, KitL, have
been localized to oocytes and granulosa cells, respectively
[16]. KitL has been shown to stimulate mouse oocyte
growth [17,18], and increased KitL in follicular fluid from
women undergoing in vitro fertilization (IVF) has been
correlated with successful pregnancies [19]. KitL is
expressed in granulosa cells as either membrane-bound or
soluble proteins arising from alternatively spliced mRNAs
[20]. Soluble KitL (KitL-1) can be cleaved due to the pres-
ence of an 84 base pair exon (exon 6), which encodes a
proteolytic cleavage site, allowing the extracellular
domain to be released as a soluble product. Membrane-
bound KitL (KitL-2) lacks this exon, is not efficiently
cleaved and thus remains more stably on the membrane
[20]. The ratio of KitL-1/KitL-2 mRNA differs between tis-
sues [20], between ovaries of mice of different ages [21],
and between granulosa cells of preovulatory and ovula-
tory rat follicles [22], suggesting that these transcripts are
differentially regulated.
Kit, the receptor for KitL, is expressed in oocytes at all
stages of follicular development in the mouse ovary [23],
and several studies have demonstrated that female mice
with naturally occurring mutations in KitL or Kit are infer-
tile due to developmental abnormalities [23,24]. For
example, mice homozygous for the KitLSld allele, which
produce only KitL-1, are sterile due to a deficiency in germ
cells [25]. However, mice that exclusively produce KitL-2
are fertile [26], suggesting that KitL-2 may be the principal
isoform required for oocyte development. Indeed, KitL-2
has been reported to induce a more persistent activation
of Kit receptor kinase than the soluble form of KitL
[27,28], and thus is likely to be the more potent isoform
for regulation of oocyte growth.
In the two species (mouse and sheep) in which Kit/KitL
and ovarian function have been most studied, there is evi-
dence for expression of both ligand and receptor mRNA
and/or protein, throughout the entire process of gonadal
formation and follicular development, except in the early
phase of meiosis I, prior to follicle formation [24,29,30].
In fetal gonads, an anti-apoptotic effect of Kit-KitL interac-
tions on primordial germ cells, oogonia and oocytes has
been demonstrated [24]. In postnatal ovaries, the initia-
tion of follicular growth from the primordial pool and
progression beyond the primary follicle stage appear to
involve Kit-KitL interactions. Treatment of neonatal rat
ovaries with recombinant KitL for 5 or 14 days in vitro
increased the percentage of follicles in the growing pool,
compared with ovaries cultured in control medium [31].
Yoshida et al. [32] have provided evidence of a role for Kit-
KitL interactions at several stages of follicular develop-
ment in vivo, by injection of an anti-Kit antibody into mice
at different times during the first 2 weeks of life. A block-
age of Kit function was found to affect the onset of pri-
mordial follicle development, primary follicle growth,
follicular fluid formation, and preovulatory follicle devel-
opment [32]. Moreover, it was shown that follicular
growth was dependent on Kit during the first 5 days after
birth, a period characterized by the absence of a func-
tional FSH receptor [32]. These findings suggest a require-Reproductive Biology and Endocrinology 2006, 4:19 http://www.rbej.com/content/4/1/19
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ment for Kit signaling during FSH-independent follicular
growth, as well as a role for Kit and its ligand in the matur-
ing ovarian follicle.
In addition to its roles in the survival of fetal germ cells
and initiation of follicular growth, there is increasing evi-
dence for the importance of Kit/KitL activity for oocyte
growth during preantral follicle development. Expression
of both KitL and Kit in the ovary is consistent with a role
for this ligand-receptor pair in oocyte growth [21], and a
role for KitL in promoting early oocyte growth (in 8-day-
old mice) in vitro has been demonstrated [17]. However,
Cecconi et al. [33] reported no effect of soluble KitL on the
growth of oocytes from 12-day-old mice, suggesting that
KitL may have different actions at different stages of
oocyte development. It may be that the actions of KitL are
modulated by the presence of gap junctions, as Klinger
and de Felici [34] have identified distinct stages of oocyte
growth based on the ability of KitL alone to induce oocyte
growth before transition to a growth phase that requires
both KitL and contact with granulosa cells. Changes in the
relative abundance of each KitL isoform may also permit
differing actions at each stage of development. Work in
our laboratory has shown that in oocyte-granulosa cell
complexes (OGCs) cultured in the presence of a low con-
centration of FSH, the ratio of steady-state KitL-1/KitL-2
mRNA was decreased due to an increase in KitL-2 mRNA
levels [18]. Importantly, this expression pattern was asso-
ciated with increased oocyte growth in culture, suggesting
that the correct balance of KitL-1/KitL-2 production is nec-
essary for optimum oocyte growth in vitro [18]. In order to
determine the specific role of each KitL isoform in pro-
moting murine oocyte growth and maintenance of mei-
otic arrest in vitro, we have performed further experiments
in which growing murine oocytes were cultured for 2 days
on monolayers of KitL-deficient fibroblasts or on fibrob-
lasts that stably express transfected constructs encoding
either KitL-1 or KitL-2. The results of assessment of oocyte
diameters and morphologies suggest that KitL-2 is the
principal isoform required to promote the growth and
survival of isolated growing oocytes [35].
Kit signaling during follicular development
Binding of KitL to the Kit receptor leads to the phosphor-
ylation of a set of cellular proteins via the kinase domain
of the Kit receptor on its cytoplasmic tail [36-38]. Conse-
quently, several signaling pathways that regulate apopto-
sis are activated via factors including Ras, Raf, mitogen
activated protein kinase (MAPK) and protein kinase B
(PKB/Akt) [39,40]. KitL stimulation also induces activa-
tion of phosphatidylinositol (PI) 3-kinase (PI3K), which
is required for KitL-induced mitogenesis and survival [41].
In rat ovaries, Jin et al. [42] have demonstrated that one of
the key downstream effectors of Kit activation is the PI3K/
Akt module, through which the signal is transduced fur-
ther downstream and converted into changes in expres-
sion of Bax and Bcl-xL that are important players in the
apoptotic pathway. By using an inhibitor of PI3K during
the culture of growing mouse oocytes on fibroblasts exclu-
sively expressing KitL-2 (as described above), we have
recently found that membrane-bound KitL-2 promotes
the growth and survival of oocytes via a PI3K-mediated
mechanism (Thomas and Vanderhyden, unpublished
observations). Further experiments are being carried out
to assess the levels of total Akt and activated Akt in oocytes
cultured in the absence of KitL, and well as in the presence
of KitL-1 or KitL-2.
Growth Differentiation Factor-9 (GDF9) and Bone 
Morphogenetic Protein-15 (BMP15)
GDF9 has been shown to be expressed in several species,
including human and mouse ovaries [43,44], and appears
to be localized exclusively to oocytes at all stages of follic-
ular growth, except primordial follicles, in neonatal and
adult mice [44]. In gdf9-/- mice, follicular development is
arrested at the primary stage [45]. The pattern of gdf9
expression, as well as results from gdf9  gene knockout
studies suggest that this factor may play an autocrine role
in the regulation of oocyte development and maturation
and/or function as a paracrine factor in the regulation of
granulosa cell proliferation and differentiation [45,46].
BMP15 is an oocyte-specific homologue of GDF9, and has
been cloned in mice [47]. In sheep, where this factor has
been well studied, the Inverdale fecundity gene (FecX) car-
ries an inactivating mutation in bmp15 [48], implicating
this factor in the control of ovulation rate. As with GDF9,
BMP15 has also been reported to play a role during sev-
eral stages of follicular development [49].
In rodents, both GDF9 and BMP15 promote proliferation
of granulosa cells from small antral follicles [50-52].
BMP15 has also been reported to inhibit FSH-stimulated
progesterone production by rat granulosa cells [51], and is
an inhibitor of luteinization [49]. At earlier stages of fol-
licular development, gdf9 and bmp15 are predominantly
expressed in oocytes of growing follicles; however, mRNA
transcripts of these genes have been detected in primor-
dial follicles of some species. In particular, in cattle, sheep
and humans, expression of gdf9 was detected in oocytes of
primordial follicles, whereas bmp15 expression was first
detected in oocytes of primary follicles [48,53,43]. The
significance of the species differences in the expression of
these genes remains to be elucidated; however, a role for
either GDF9 or BMP15 in activation of primordial folli-
cles remains controversial. For example, ewes that were
actively immunized against GDF9 became anovulatory
and the ovaries contained few follicles beyond the pri-
mary stage [54], suggesting that the major role for GDF9
is from the primary stage onwards. Oocytes that were
larger than those in normal primary follicles were alsoReproductive Biology and Endocrinology 2006, 4:19 http://www.rbej.com/content/4/1/19
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observed after immunization, reminiscent of those seen
in  gdf9  knockout mice. Immunization against BMP15
yielded a similar phenotype [54]. In contrast, recom-
binant GDF9 has been shown to promote the develop-
ment of human primordial follicles to the secondary stage
in culture, as well as improve follicular survival [55]. Fol-
lowing previous observations regarding the role of GDF9
in follicular development [45], new evidence has now
emerged to suggest that GDF9 plays a role in the primor-
dial to primary follicle transition in mice [56]. It is clear
that more studies are required to determine the signifi-
cance of GDF9 and BMP15 action in primordial follicles,
as well as the role of these factors in follicular develop-
ment in humans.
GDF9 and BMP15 signaling
Members of the TGF-β superfamily signal via type-I and
type-II receptors present on granulosa cells [49]. Upon lig-
and binding, the type-II receptors activate type-I receptors
by phosphorylation; the receptors complex, then phos-
phorylate intracellular signaling molecules called Smads
[57]. The specific Smad proteins whose activities depend
GDF9, BMP15 and KitL interactions during oocyte and follicular development Figure 1
GDF9, BMP15 and KitL interactions during oocyte and follicular development. Interactions among factors derived 
from oocytes and granulosa cells are regulated by FSH, and are important for oocyte development. In rodents, both GDF9 and 
BMP15 have been shown to promote proliferation of granulosa cells from small antral follicles, and BMP15 has been reported 
to inhibit FSH-stimulated progesterone production, and is an inhibitor of luteinization. Evidence from studies with gdf9-/- mice 
and granulosa cell cultures indicate that GDF9 suppresses expression of both KitL-1 and KitL-2. In contrast, BMP15 promotes 
KitL expression in monolayers of granulosa cells from rat early antral follicles and enhances the expression of both KitL-1 and 
KitL-2 mRNA in mouse oocyte-granulosa cell complexes grown in vitro. FSH is known to regulate bmp15 expression in a dose-
dependent manner via Kit signaling, and Kit signaling promotes both oocyte growth and cell survival. Black lines indicate 
actions; red lines indicate effects on mRNA expression. The thick black arrow denotes the relative importance of KitL-2 in 
activating Kit receptors to promote oocyte growth.
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on phosphorylation by type-I receptors are called receptor
regulated Smads (R-Smads) [58-60]. The R-Smads
includes Smads 1, 2, 3, 5 and 8. Once activated, the R-
Smad molecules interact with another Smad, Smad 4,
which is a common partner for all R-Smads. The Smad
complex then translocates to the nucleus to interact with
specific transcription factors to regulate the expression of
target genes.
Although both GDF9 and BMP15 are members of the
TGF-β superfamily, there is a distinct divergence of signal-
ing pathways used by these oocyte-specific factors [57].
Both GDF9 and BMP15 signal through the BMP type-II
receptor (BMPRII) [61]; however, GDF9 uses the ALK5
type-I receptor, and signals through the pathway activated
by TGF-β and activin [62], whereas BMP15 signals
through the ALK6 type-Ib receptor [63]. The intracellular
signal for GDF9 is mediated through the phosphorylation
of Smads 2 and 3, whereas the phosphorylation of Smads
1, 5 and/or 8 mediates the signaling of the majority of
BMP ligands [49].
From examination of inherited patterns of ovulation rate
in sheep, several breeds have been identified with point
mutations in bmp15, gdf9 and ALK6 [64]. Five different
point mutations have been identified in the bmp15 gene,
one in gdf9 and one in ALK6. Animals homozygous for
the bmp15 or gdf9 mutations are anovulatory whereas ani-
mals heterozygous for bmp15 or gdf9 mutations and those
heterozygous or homozygous for ALK6 mutations have
higher than normal ovulation rates. Moreover, immunisa-
tion of ewes against BMP15 or GDF9 shows that both are
essential for normal follicular development and control of
ovulation rate [65].
Interactions between KitL, GDF9 and BMP15
While KitL, GDF9 and BMP15 may play distinct roles dur-
ing follicular development, it is now clear that there are
also significant interactions among these factors
[18,66,67] (Figure 1). Recombinant GDF9 inhibits KitL
mRNA expression in mouse preantral granulosa cells [66],
whereas BMP15 promotes KitL expression in monolayers
of granulosa cells from rat early antral follicles [67]. In
addition, we have provided evidence of communication
between BMP15 and KitL at the molecular level in intact
murine OGCs in vitro [18]. By inhibition of Kit activity
within OGCs in vitro, we have shown that FSH regulates
bmp15 expression in a dose-dependent manner via Kit sig-
naling [18]. Thus, interactions between oocyte- and gran-
ulosa cell-derived factors are regulated by FSH, which
appears to fine-tune levels of expression of the paracrine
factors.
Oocytes within gdf9-deficient mouse ovaries grow larger
than normal [45,56]; however, these oocytes do not
acquire full developmental competence [46]. Interest-
ingly, these mutant mice also have elevated levels of KitL-
1 and KitL-2 mRNA [46,56], which suggests that GDF9
regulates KitL  expression. Differential regulation of the
two KitL transcripts is likely to be a vital component in
eliciting specific KitL-mediated actions during oocyte and
follicular development. Although the mechanisms con-
trolling the expression of the specific isoforms of KitL are
not yet defined, it is likely cell-specific, as human chori-
onic gonadotropin has been shown to affect KitL isoform
expression differently in mural vs. cumulus granulosa
cells [22]. Stage-specific changes may also be important,
since down-regulation of KitL-2 expression occurs during
early antral follicle formation, coinciding with the cessa-
tion of oocyte growth [18]. Oocytes in gdf9 deficient mice
may thus exceed the normal maximum diameter due to
consistently elevated levels of KitL-2 expression.
The role of FSH in regulating oocyte-follicle 
interactions
Endocrine control of follicular development by FSH rests
on a network of intrafollicular paracrine interactions [68].
For example, FSH promotes proliferation and differentia-
tion of preantral follicles via paracrine factors such as IGF-
1 and activin [69,70]. In addition, FSH regulates KitL
expression in granulosa cells from murine preantral folli-
cles [71]. We have recently investigated the role of FSH in
the regulation of KitL expression during the development
of mouse preantral oocyte-granulosa cell complexes in
vitro [18]. It was demonstrated that a low concentration of
FSH decreased the ratio of steady-state KitL-1/KitL-2
mRNA by increasing KitL-2 mRNA levels, and this was
associated with increased oocyte growth in culture [18].
These results suggest that the correct balance of KitL-1/
KitL-2 production is necessary for optimum oocyte
growth in vitro. In addition, the correct concentration of
FSH is crucial for appropriate regulation of paracrine fac-
tors to promote oocyte development. In granulosa-luteal
cells obtained after oocyte harvest from patients undergo-
ing IVF, a decrease in KitL mRNA expression was reported
in response to FSH and hCG in a time- and concentration-
dependent manner in vitro [72], suggesting that KitL is
hormonally regulated in humans and is likely to partici-
pate in follicular function during the human menstrual
cycle.
Studies using mice with deficiencies in FSH receptor (FSH-
R) expression have allowed further elucidation of the role
of FSH in oocyte-granulosa cell interactions. It has been
reported that mice lacking the FSH-R gene have structural
alterations in the ovary at or before 2 days of age [73]. Fur-
thermore, there is evidence to suggest that FSH-R deletion
results in changes in oocyte structure and function, and
disruption of oocyte-granulosa cell communication [74].
Specifically, oocyte growth was reduced in the FSH-R nullReproductive Biology and Endocrinology 2006, 4:19 http://www.rbej.com/content/4/1/19
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mice, and the expression of Kit, KL and BMP15 proteins
was decreased in both null animals and heterozygotes.
These findings not only suggest that oocyte development
is impaired when FSH signaling is impeded, but also that
bidirectional communication between the oocyte and
granulosa cells is influenced in a quantitative manner by
FSH-R signaling events in the perinatal/postnatal period
[74].
Transzonal Processes (TZPs) and gap junctions 
mediate oocyte-granulosa interactions
Efficient delivery of factors to and from the oocyte at crit-
ical stages of development is essential for the coordina-
tion of oogenesis and folliculogenesis, and is influenced
by the structural features of the oocyte-granulosa cell
interface [75]. TZPs, which are granulosa cell extensions
that traverse the zona pellucida and terminate on the
oocyte cell surface, have been characterized by electron
microscopy in many mammals, including mouse, rat and
human [75,76]. These TZPs have been shown to undergo
dynamic alterations in form and number during the
course of follicular development [76]. They are most
numerous at the preantral stage, forming adhesive and
gap junctional contacts at the oolema. During peak peri-
ods of oocyte growth, TZPs extend as deep invaginations,
impinging on the oocyte germinal vesicle [76]. FSH has
recently been shown to regulate the ability of granulosa
cells to make connections with the oocyte [77]. In that
study, it was shown that FSH treatment of pre-pubertal or
FSHβ-knockout mice decreased the density of TZPs, which
coincided with changes in chromatin remodeling and
acquisition of oocyte meiotic competence [77]. Clearly
these processes are important for oocyte development,
although the interactions between these structural fea-
tures and the paracrine factors that control oocyte growth
still need to be elucidated.
TZPs enable the formation of intercellular gap junctions
that are necessary for normal follicular development. The
stage-specific pattern of distribution of different types of
the gap junctional proteins, connexins, has been estab-
lished in murine follicles [78]. KitL has been shown to
induce the onset of in vitro growth of isolated fetal mouse
oocytes, in the absence of gap junctional communication
with granulosa cells [34]. However, these oocytes were
unable to progress to the final stages of growth, and there
was a lack of synchrony between nuclear and cytoplasmic
maturation. The authors noted that these oocytes had
characteristics resembling oocytes from connexin-43 and
-37-deficient mice, which have impaired follicular devel-
opment beyond the preantral and early antral stages,
respectively [79,80], thus it was hypothesized that the pre-
antral/antral transition is a critical stage of oocyte devel-
opment requiring the coordinated differentiation of the
oocyte with the granulosa cells [34]. The maintenance of
adequate communication between these two cell types
during the preantral and early antral stages is therefore
necessary to ensure subsequent oocyte developmental
competence. Gittens et al. [81] have provided evidence for
interplay between paracrine signaling and gap junctional
communication. In that study, expression of KitL, Kit and
gdf9 were analyzed in connexin-43 deficient mice, and the
expression of connexin-43 was analyzed in gdf9 deficient
mice. The results suggest that although gap junctional
coupling among granulosa cells is not required to sustain
expression of these paracrine factors, and GDF9 is not
required to sustain gap junctional coupling among granu-
losa cells, granulosa cells must be coupled via connexin-
43 gap junctions in order to optimally respond to GDF9
[81].
Conclusion
At present, the major barrier to developing and optimiz-
ing  in vitro techniques for alleviation of infertility in
women is our lack of knowledge of how the oocyte
acquires developmental competence during its growth
within the follicle. There is substantial evidence to indi-
cate that oocyte-granulosa cell interactions are essential
for the proper coordination of oocyte and follicular devel-
opment. Researchers during the past decade have devel-
oped and explored a variety of in vitro and in vivo model
systems to reveal the identity and functions of several pro-
teins, notably KitL, GFD9 and BMP15, which mediate at
least some of the communication between oocytes and
their surrounding granulosa cells. KitL is critical for the
growth of oocytes, and its level of expression is differen-
tially controlled by paracrine and hormonal factors. The
early evidence suggests that gap junctional communica-
tion is not necessary to sustain KitL expression; however,
both overall expression and the relative abundance of KitL
isoforms are influenced by GDF9, BMP15 and FSH at var-
ious stages of follicular development. While current
research suggests that KitL-2 is more efficient at stimulat-
ing oocyte growth, the molecular mechanisms that pro-
mote the acquisition of developmental competence
remain unknown. Identification of the factors or patterns
of expression that contribute to the growth of healthy
oocytes with full developmental competence, and that
can be used as indicators of oocyte quality, have potential
impact on the establishment of in vitro growth systems for
clinical application, as well as on pregnancy outcome and
offspring health.
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